Navigation Links

Worthy Start of the Year for Biotech Companies

NEW YORK , January 20, 2017 - According to World Health Organization, cancer is one of leading causes of death worldwide. There were 8.2 million cancer related deaths in 2012. Although the number of cancer related deaths increased gradually over time, the death rates have declined since 1990. Rising in incidence rate of various cancers continue... [Comments]

SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand

MALDEN, MA (PRWEB) January 20, 2017 SpineFrontier, Inc., the leader in Less Exposure Surgery (LES®) Technologies, announced today the next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System (part of the PedFuse Pedicle Screw System platform). In contrast to the co... [Comments]

Cancer Biomarkers Market - Global Opportunity Analysis and Industry Forecast 2014-2022: Omics Accounted for More Than Half of the $6.5 Billion Market - Research and Markets

DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Cancer Biomarkers Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. Cancer Biomarkers Market Report, forecasts that the global market is projected to reach $15,737 mi... [Comments]

Liquid Biopsy Market is Predicted to Grow at a CAGR of 21.6% from 2016 to 2022

PUNE, India , Jan. 19, 2017  Market Research Future has a half cooked research report on Global Liquid Biopsy Market. The Global Market for Liquid Biopsy is growing rapidly and expected to reach USD 450 Million by the end of the forecasted period. Market Highlights The Global Liquid Biopsy Market has been assessed as a swiftly growing market and expect... [Comments]

NX Prenatal Appoints Leading Experts to Medical/Clinical Advisory Board

LOUISVILLE, Ky. and HOUSTON , Jan. 19, 2017 NX Prenatal Inc. ("NX Prenatal") today announced the formation of its Medical/Clinical Advisory Board.  This new board brings together leading clinicians and industry veterans who enhance the range and depth of expertise of the company as it accelerates development of its novel prenatal diagnostic tests.  These experts... [Comments]

WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

SHANGHAI , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that it has acquired HD Biosciences (HDB), a leading biology focused preclinical drug discovery contract research organization (CRO). After completion of acquisition, HD Biosciences will become a wholly-owned sub... [Comments]

Implantable Biomaterials Market Material, Application Analysis & Trends 2016-2025: $150+ Billion Growth Opportunities/Investment Opportunities - Research and Markets

DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Implantable Biomaterials Market Analysis & Trends - Material, Application - Forecast to 2025" report to their offering. Report Highlights: The report provides a detailed analysis on current and future market trends to identify the investment opportunities... [Comments]

Genedata Launches Data Science Services for Precision Medicine

Basel, Switzerland (PRWEB) January 19, 2017 Genedata, a leading provider of advanced software solutions for pharmaceutical research and development (R&D), today announced the launch of Data Science Services , offering on-demand, project-based expertise in omic data analysis and interpret... [Comments]

November Research Group Announces the Availability of PRIMO Mail

Berkeley, CA (PRWEB) January 19, 2017 November Research Group, LLC, a global leader in the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide release of PRIMO Mail. PRIMO Mail is a fully 21 CF... [Comments]

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

ANNAPOLIS, Md. and GAITHERSBURG, Md. , Jan. 19, 2017  PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced today the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an all-stock transaction. Altimmune's current investors include Novartis Venture Fund,... [Comments]

[previous] [next]
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at ... possibilities for graphene by combining the material with ... highly sensitive pressure detector able to sense pulse, ... a small spider.  The research ... can be read here: ...
(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016  Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...
(Date:12/7/2016)... , December 7, 2016 BioCatch , the ... of its patent portfolio, which grew to over 40 granted and pending ... , , ... filed patent entitled " System, Device, and Method Estimating Force ... enables device makers to forego costly hardware components needed to estimate the ...
Breaking Biology News(10 mins):
... be superior to transfection in some applications. ... PULSin you can study lethal proteins and ... proteins in cells. Likewise, delivery of blocking ... RNA interference experiments. ,With PULSin you ...
... delivery using PULSin may be superior to ... unlike traditional transfection, with PULSin you can ... and time course of proteins in cells. ... more information than traditional RNA interference experiments. ...
... FACSVantageTM SE flow cytometry system is the ... For over 25 years, BD cell sorters ... found in leading university, pharmaceutical, and biotechnology ... meet the research demands of today, we ...
Reacti-Bind DNA Coating Solution...
Biology Products:
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
(Date:1/19/2017)... Staten Island, NY (PRWEB) , ... January 19, 2017 , ... ... expand at an exponential rate. The tremendous growth is accounted to two main ... to the table and the expanding network of vendors supplying FireflySci products all around ...
(Date:1/19/2017)... , Jan. 18, 2017 Acupath Laboratories, Inc., ... the formation of an Executive Committee that will guide ... John Cucci , a 15-year veteran ... Director of Business Development to Chief Sales Officer ... Cucci served in senior sales leadership roles at several ...
(Date:1/18/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, will feature data from two clinical ... 2017 ASCO Gastrointestinal Cancers Symposium, held from January 19-21, ... Napabucasin is an orally-administered investigational agent designed to ... Cancer stem cells (CSCs) possess the property of stemness ...
Breaking Biology Technology: